Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1998-3-24
|
pubmed:abstractText |
Vanadium has been found to be orally active in lowering plasma glucose levels; thus it provides a potential treatment for diabetes mellitus. Bis(maltolato)oxovanadium(IV) (BMOV) is a well-characterized organovanadium compound that has been shown in preliminary studies to have a potentially useful absorption profile. Tissue distributions of BMOV compared with those of vanadyl sulfate (VS) were studied in Wistar rats by using 48V as a tracer. In this study, the compounds were administered in carrier-added forms by either oral gavage or intraperitoneal injection. Data analyzed by a compartmental model, by using simulation, analysis, and modeling (i.e., SAAM II) software, showed a pattern of increased tissue uptake with use of 48V-BMOV compared with 48VS. The highest 48V concentrations at 24 h after gavage were in bone, followed by kidney and liver. Most ingested 48V was eliminated unabsorbed by fecal excretion. On average, 48V concentrations in bone, kidney, and liver 24 h after oral administration of 48V-BMOV were two to three times higher than those of 48VS, which is consistent with the increased glucose-lowering potency of BMOV in acute glucose lowering compared with VS.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrones,
http://linkedlifedata.com/resource/pubmed/chemical/Vanadates,
http://linkedlifedata.com/resource/pubmed/chemical/Vanadium Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/bis(maltolato)oxovanadium(IV),
http://linkedlifedata.com/resource/pubmed/chemical/vanadyl sulfate
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
8750-7587
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
84
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
569-75
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9475867-Animals,
pubmed-meshheading:9475867-Computer Simulation,
pubmed-meshheading:9475867-Hypoglycemic Agents,
pubmed-meshheading:9475867-Male,
pubmed-meshheading:9475867-Models, Biological,
pubmed-meshheading:9475867-Pyrones,
pubmed-meshheading:9475867-Rats,
pubmed-meshheading:9475867-Rats, Wistar,
pubmed-meshheading:9475867-Tissue Distribution,
pubmed-meshheading:9475867-Vanadates,
pubmed-meshheading:9475867-Vanadium Compounds
|
pubmed:year |
1998
|
pubmed:articleTitle |
Kinetic analysis and comparison of uptake, distribution, and excretion of 48V-labeled compounds in rats.
|
pubmed:affiliation |
Chemsitry Department, University of British Columbia, Vancouver, Canada.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|